Glial Fibrillary Acidic Protein Human ELISA (GFAP)

Catalog number: RD192072200R
Brand: BioVendor
Packing: 96 wells
Price: € 613.00
Expected delivery time: 7 days
Quantity:

Product specifications for - Glial Fibrillary Acidic Protein Human ELISA (GFAP)

Overview: 
Product group: Assays
Category: ELISA / EIA
Properties: 
Molecular weight: 40 and 53 kDa
Assay Sensitivity: 0,045 ng/ml
Assay Precision: Inter assay: n = 7, CV = 5,7%, Intra assay: n = 8, CV = 5,1%,
Assay Sample Type: serum, cerebrospinal fluid (CSF) and plasma
Assay Time: The total assay time is about 5 hours
Assay Detection Range: 0,25 - 25 ng/ml
  Research Use Only
UNSPSC: 41116158
Storage instructions: Store the complete kit at 2-8-¦C. Under these conditions, the kit is stable until the expiration date (see label on the box).
Scientific information: 
Scientific info: Glial Fibrillary Acidic Protein (GFAP), as a member of the cytoskeletal protein family, is the principal 8-9 nm intermediate filament in mature astrocytes of the central nervous system (CNS). GFAP is a monomeric molecule with a molecular mass between 40 and 53 kDa and an isoelectric point between 5.7 and 5.8. GFAP is highly brain specific protein that is not found outside the CNS. Some studies showed that GFAP is released into the blood very soon after traumatic brain injury (TBI), that GFAP is related to brain injury severity and outcome after TBI and that GFAP is not released after multiple trauma without brain injury. In the CNS following injury, either as a result of trauma, disease, genetic disorders, or chemical insult, astrocytes become reactive and respond in a typical manner, termed astrogliosis. Astrogliosis is characterized by rapid synthesis of GFAP. GFAP normally increases with age and there is a wide variation in collection and processing of human brain tissue. Thanks to the high brain specificity and early releasing from CNS after TBI, GFAP might be suitable marker for early diagnostics. Areas of investigation: Brain injury, Ischemic stroke.
Additional information: 
Synonyms: RD192072200R; BioVendor
Boutsikou T, Briana DD, Boutsikou M, Kafalidis G, Piatopoulou D, Baka S, Hassiakos D, Gourgiotis D, Malamitsi-Puchner A. Cord blood nesfatin-1 in large for gestational age pregnancies. Cytokine. 2013 Feb,61 (2):591-4 Read more
Brouns R, De Vil B, Cras P, De Surgeloose D, Marien P, De Deyn PP. Neurobiochemical Markers of Brain Damage in Cerebrospinal Fluid of Acute Ischemic Stroke Patients. Clin Chem. 2009 Dec 3, Read more
Dabrowski W, Rzecki Z, Czajkowski M, Pilat J. Magnesium reduces matrix metalloproteinase-9, but not glial fibrillary acidic protein, in cardiac surgery patients. Future Neurol. 2012,7(3):349-359 Read more
Ehrlich S, Burghardt R, Weiss D, Salbach-Andrae H, Craciun EM, Goldhahn K, Klapp BF, Lehmkuhl U. Glial and neuronal damage markers in patients with anorexia nervosa. J Neural Transm. 2008 Jun,115 (6):921-7 Read more
Feneberg E, Steinacker P, Lehnert S, Bohm B, Mayer G, Otto M. Elevated glial fibrillary acidic protein levels in the cerebrospinal fluid of patients with narcolepsy. Sleep Med. 2013 Jul,14 (7):692-4 Read more
Hsu AA, Fenton K, Weinstein S, Carpenter J, Dalton H, Bell MJ. Neurological injury markers in children with septic shock. Pediatr Crit Care Med. 2008 May,9 (3):245-51 Read more
Jesse S, Steinacker P, Cepek L, von Arnim CA, Tumani H, Lehnert S, Kretzschmar HA, Baier M, Otto M. Glial fibrillary acidic protein and protein S-100B: different concentration pattern of glial proteins in cerebrospinal fluid of patients with Alzheimer's disease and Creutzfeldt-Jakob disease. J Alzheimers Dis. 2009 Jul,17 (3):541-51 Read more
Jung CS, Foerch C, Schanzer A, Heck A, Plate KH, Seifert V, Steinmetz H, Raabe A, Sitzer M. Serum GFAP is a diagnostic marker for glioblastoma multiforme. Brain. 2007 Dec,130 (Pt 12):3336-41 Read more
Kaneko T, Kasaoka S, Miyauchi T, Fujita M, Oda Y, Tsuruta R, Maekawa T. Serum glial fibrillary acidic protein as a predictive biomarker of neurological outcome after cardiac arrest. Resuscitation. 2009 Jul,80 (7):790-4 Read more
Kwon BK, Stammers AM, Belanger LM, Bernardo A, Chan D, Bishop CM, Slobogean GP, Zhang H, Umedaly H, Giffin M, Street J, Boyd MC, Paquette SJ, Fisher CG, Dvorak MF. Cerebrospinal Fluid Inflammatory Cytokines and Biomarkers of Injury Severity in Acute Human Spinal Cord Injury. J Neurotrauma. 2009 Dec 28, Read more